Tuckahoe, NY, United States of America

Giuseppe Pintucci

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: New York University. Active years: 2013.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giuseppe Pintucci: Innovator in Cardiovascular Treatment

Introduction

Giuseppe Pintucci is a notable inventor based in Tuckahoe, NY (US). He has made significant contributions to the field of cardiovascular medicine through his innovative research and patents. His work focuses on improving patient outcomes following vascular procedures.

Latest Patents

Giuseppe Pintucci holds a patent for the "Inhibition of mitogen-activated protein kinases in cardiovascular disease." This invention relates to methods for inhibiting subacute thrombosis and/or intimal hyperplasia following an interventional vascular procedure. The patent describes the process of contacting a blood vessel or synthetic material with a mitogen-activated protein kinase (MAPK) pathway inhibitor. Additionally, it includes vascular devices that comprise a MAPK pathway inhibitor. He has 1 patent to his name.

Career Highlights

Giuseppe Pintucci is affiliated with New York University, where he conducts his research and develops his inventions. His work has the potential to significantly impact the treatment of cardiovascular diseases, providing new avenues for patient care.

Collaborations

He has collaborated with esteemed colleagues such as Paolo Mignatti and Aubrey Galloway, contributing to a rich environment of innovation and research.

Conclusion

Giuseppe Pintucci's contributions to cardiovascular medicine through his patent and research at New York University highlight his role as an important inventor in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…